Aging and Neurodegenerative Diseases: Models and Assessment of the Impact and Responses to ROS / RNS Kenneth Hensley Free Radical Biology and Aging Research.

Slides:



Advertisements
Similar presentations
- D A N I S H A G I N G R E S E A R C H C E N T E R - Why do we age so differently? Tinna Stevnsner for Christina Poulsen Hvitby (on maternity.
Advertisements

Etiopathogenesis of Alzheimer's disease
ALS Research Yesterday, Today and Tomorrow Heather D. Durham, PhD.
Crystallization and Dimer Exchange of the Protein Superoxide Dismutase Emily Clark Dr. Joe Beckman Department of Biochemistry/ Biophysics Oregon State.
Comparing the Toxicity of Zinc Deficient Superoxide Dismutase (SOD) and the Quad SOD mutant: Implications for Amyotrophic Lateral Sclerosis Jesse Fitzpatrick.
Astrocytic contribution to deficient Ca 2+ signalling and oxidative stress mediated by TRPV4 channels in Aβ 40 -induced hippocampal cell death Ji-Zhong.
3rd International Conference on Neurology & Therapeutics
An Investigation of the Interactions Between Zinc-deficient and Copper, Zinc Superoxide Dismutase Katie Meyers Dr. Joe Beckman Department of Biochemistry/Biophysics.
OXIDATIVE STRESS. INDUCTION OF OXIDATIVE STRESS Glutathione conjugation MalnutritionMutation Phagocytic activation Tissue damageSmoking.
Zinc-deficient SOD in ALS Emily Clark Dr. Joe Beckman Department of Biochemistry/Biophysics.
Anatomo-Histology From Table 8.10 Brain atrophy, flattening of gyri,
Copper Binding of Mutant Quad SOD1
Investigation of mutated Cu/Zn Superoxide Dismutase Sam Schuberg Beckman Laboratory Howard Hughes Medical Institute: Summer 2007.
An Investigation into Zinc Transporter Expression in an Animal Model of Amyotrophic Lateral Sclerosis By Thomas Lew Mentor: Dr. Joe Beckman Linus Pauling.
Natalie Biggs Mentor: Dr. Joseph Beckman
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
INTRODUCTION Mutations in Presenilin (PS) 1 and 2 cause familial Alzheimer’s Disease (AD) through undetermined mechanisms. PS’s are intramembranous aspartyl.
Cellular Degeneration and Ageing Susan Rutherford and Sarah Christie.
A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.
2 Huntington’s disease Parkinson’s disease Amylotrophic lateral sclerosis Alzheimer’s Disease Neurodegenerative Disorders.
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. Susan A. Farr, et al.
Amyotrophic lateral sclerosis (ALS). What is amyotrophic lateral sclerosis? It is a progressive neurological disease that affects the control of muscle.
By Intracerebroventricular Delivery of VEGF in a Rat Model of ALSEGF in a Rat Model of ALS Treatment of Motoneuron Degeneration.
Purification of CCS, copper chaperone for Superoxide Dismutase Sean McIntyre Lab: Dr. Joe Beckman.
PEPTIMMUNE CONFIDENTIAL IMMUNOMODULATORY THERAPY FOR PARKINSON’S DISEASE Induction of an anti-inflammatory immune response toward toxic species of alpha-synuclein.
Neuroprotective Effects of Memantine. Hippocampal slice cultures Brown et al., Soc. Neurosci 2003 Semi-chronic 3-NP toxicity in organotypic hippocampal.
Oxidative Stress By: Andrew Lorusso. Overview Alvaro Estevez an associate professor at the University of Central Florida led a multi-university team that.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Nitric Oxide As a Mediator of Apoptosis Mallika Somayajulu.
Nitric Oxide Synthase in Mouse Brain Tissue that Exhibits Alzheimer’s Disease Patrick McCarthy
The aging phenotype: cellular aspects A&S Jim Lund.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Alzheimer’s Disease By: Chelcy Branon. Facts  In 2006, there were 26.6 million sufferers worldwide  Costs 100 billion dollars per year.
Aging Nervous System. Neurotrophic Factors Necessary for Maintenance of Neurons Neurotrophin function o Play role in development of NS o Interact with.
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
Determining the Role of GPX, an antixodant, in the Inflammatory Changes Associated with Emphysema Navida Bholanauth Dr. Jeanine D’Armiento Columbia University.
The effect of copper chelators on Zn(-) Superoxide Dismutase Lucy Brennan Dr. Joe Beckman Dr. Kari Trumbull.
Pathogenesis of Cerebral Infarction at Cellular & Molecular Levels By: Reem M Sallam, MD, PhD.
Aging and Reactive oxygen Species. Aging: What is it?  Aging, has been termed generally as a progressive decline in the ability of a physiological process.
漸凍症 amyotrophic lateral sclerosis. Lou Gehrig's disease 1939 Jean-Martin Charcot Amyotrophic lateral sclerosis (ALS) (Rosen DR et al. Nature 1993) 1869.
Determining the Efficacy of the KillerRed/IL-13.E11Y Fusion Protein: A Cytotoxic, Photo-activated Protein Designed to Target Glioblastomas Fusion E. ColiKR.
Trafficking and processing of APP  and  -secretase.
Mitochondrial function is essential for life. Increasing attention is paid to mitochondrial dysfunction as this is coupled to many metabolic and age-related.
Protection of rat primary hippocampal cultures from Aβ cytotoxicity by pro-inflammatory molecules is mediated by astrocytes Neurobiology of disease, Vol.
© TND 2005 Oxidative Stress and Inflammation in Neurodegenerative Diseases George Perry and Mark A. Smith Case Western Reserve University Cleveland, Ohio.
Dr. Sigal fleisher-Berkovich Neuroinflammation is regulated by angiotensin related drugs: possible implications for neurodegenerative diseases.
Iron accumulation in Patients with Parkinson’s Disease
Superoxide Dismutase and Amyotrophic Lateral Sclerosis
Cell Aging. Aging is generally characterized by the declining ability to respond to stress, increasing homeostatic imbalance and increased risk of aging-associated.
Effects of Cystamine, a Transglutaminase Inhibitor in a Mouse Model of Progressive Supranuclear Palsy Michael Zorniak Department of Biology Lake Forest.
Recent advances in Trace Element Research in Health and Disease Dubrovnik, Oct 2015 Mirjana Babić Leko, mag.biol.mol Department of Neuroscience Croatian.
Under the supervision of miklós jászberényi
Role of heat shock proteins in aging
Amyotrophic Lateral Sclerosis
N deg - 1 Characteristics of neurons u Cytoskeletal organization u Microtubules and motors u Neuronal intermediate filaments u Neurofilaments u Peripherin,
Neuroprotective Effects of Memantine. Hippocampal slice cultures Brown et al., Soc. Neurosci 2003 Semi-chronic 3-NP toxicity in organotypic hippocampal.
Amyotrophic Lateral Sclerosis (ALS). Also know as Lou Gehrig's Disease Named after the New York Yankees baseball star who played first base and was diagnosed.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Trends in Biomedical Science Theories of Alzheimer’s Disease.
A Correlation Between Alzheimer’s and Parkinson’s: Inflammatory Response to Endogenous Neuro-protective Mechanisms Peter H. Massey.
ENDOCANNABINOID REGULATION OF ALTERNATIVE MICROGLIA ACTIVATION IN MULTIPLE SCLEROSIS CAITLIN JAGLA.
Camara M1, Anscomb H.L. 2 and Baune B.T. 1,2
Protein conformational disorders
A potential therapy for ALS
Figure 3 VEGF in neurodegenerative disease
Mechanisms Underlying Inflammation in Neurodegeneration
Alzheimer’s Disease Neurobiology
Ilaria Ghia & Fabio Grieco
Table 1. Bioactive properties in Coriolus versicolor
Presentation transcript:

Aging and Neurodegenerative Diseases: Models and Assessment of the Impact and Responses to ROS / RNS Kenneth Hensley Free Radical Biology and Aging Research Program Oklahoma Medical Research Foundation

Overview Discussion of Alzheimer’s disease and amyotrophic lateral sclerosis (ALS) Methods for studying oxidative stress with examples From recent human and animal studies What the animal models are beginning to tell us about the relationship of oxidative stress to neuroinflammation

Oxidative Damage in Neurological Disease Implicated in: rodent models: Alzheimer’s disease (AD)Several genetic models e.g. Tg2576, APP/PS1 mice Amyotrophic lateral sclerosis G93A-SOD1, G85R SOD1, (ALS, Lou Gherig’s disease) other SOD1 mice; ALS2 mouse peripherin mouse Huntington’s disease R6/2 mouse, 3-nitropropionate Parkinson’s disease MPTP induced lesions; LPS- induction models StrokeGerbil, rat models for carotid and MCAO occlusion

Alzheimer’s Disease Characterized by amyloid protein deposition in plaques and by intraneuronal inclusions of various proteins (eg. hyperphosphorylated tau) Glial activation around plaques, and associated neuron damage / death Region-specific accumulation of oxidative damage that correlates with histopathology

Histopathology of AD: Plaques and Tangles Histochemistry: anti-phospho-p38 / cresyl violet

Oxidative damage to brain can be measured (sometimes) using HPLC with electrochemical detection

* * * * * * Protein 3-NO 2 -Tyr is Elevated Region-Selectively in Human AD Brain Hensley et al., J. Neurosci. 18: (1998)

retention time (minutes) response (nA) TT 5-NO 2 -  T TT R = CH 3  -tocopherol R = H  -tocopherol R = NO 2 5-NO 2 -  -tocopherol Lipid phase nitration: 5-NO 2 -  -tocopherol can be detected in AD brain tissue using HPLC-ECD

5-NO 2 -  -tocopherol is elevated in the AD brain in a region-selective manner that correlates with 3-NO 2 -Tyr elevations 5-NO 2 -  -tocopherol /  - tocopherol * normal AD * normal AD IPL SMTG CBL Williamson et al., Nitric Oxide: Biol Chem, 6: (2002)

Brain protein carbonyl load increases with age and further increases in Alzheimer’s diseased cortex Smith et al., Proc. Natl. Acad. Sci. USA 88: (1991)

Mouse models of AD partially reproduce the oxidative damage aspect of the disease Lim et al., J. Neurosci. 21: (2001)

Oxidative damage in humans and animal models of ALS ALS is a fatal motor neuron disease causing death of neurons in the spinal cord, brainstem and motor cortex. It is essentially untreatable (+6 month life extension with the NMDA receptor antagonist riluzole). Prognosis: Progressive paralysis followed by death in 3-5 years. Death is usually by pneumonia and near complete paralysis.

ALS may be sporadic or familial About 20 % of all ALS cases are heritable Of these, 20-30% are caused by gain-of-toxic Function mutations in Cu,Zn-SOD (SOD1) [Deng et al. Science 20: (1993)] 2O 2 – + 2 H + H 2 O 2 + O 2 SOD1 SOD1 normally detoxifies ROS; it is unclear what is the toxic gain-of-function associated with mutant SOD1.

Cu,Zn-Superoxide Dismutase (SOD1) SOD1 knockout mice are viable; no CNS disease. Human wild-type SOD1 over-expressing mice are healthy Mutant SOD1 causes ALS-like disease in mice when ubiquitously expressed but not when expression is specifically targeted to neurons (Pramatarova et al. 2001; Lino et al. 2002)

Why do mutant SOD1 enzymes cause motor neuron disease? SOD1 mutants have increased peroxidase activity and convert H 2 O 2 to  OH (Valentine and Bredesen 1996; Yim et al. 1997) Mutant SOD1 lose metals easily. Metal deficient enzymes promote protein nitration and render neurons susceptible to apoptosis (Crow, Beckman et al. 1997; Estevez et al. 1999) SOD1 mutants aggregate inside neurons, contribute to toxicity (Bruijn et al. 1998)

Alternative Explanations Maybe SOD1 mutants exert their pathogenic effects through non- neuronal cells. Neuroinflammation: ROS, RNS cytokines apoptosis initiators limited involvement of lymphocytes astrocytes microglia

Transgenic mice expressing the G93A-SOD1 mutation develop ALS-like disease

G93A-SOD1 mutant mice experience progressive decline in motor function

+ pH 5.5 (MES) o C, 8 H biotin hydrazide oxidized protein stable hydrazone derivative, detectable with streptavidin-HRP and standard chemiluminescence reagents Protein carbonyl assessment with biotin hydrazide as developed to study protein oxidation in ALS Hensley et al., J. Neurochem. 82: (2002)

Protein carbonyl levels are increased in the G93A- SOD1 mouse spinal cord at 120 D Hensley et al., J. Neurochem. 82: (2002) Andrus, Fleck and Gurney J. Neurochem. 71: (1998)

Where are these ROS coming from? Hypothesis: Activated microglia, dysregulated cytokine networks and the neuroinflammatory process

IL10 IL1  IL1  IL1RA IL18 IL6 IFN  MIF L32 GAPDH nonTg G93A-SOD1 RPA analysis indicates broad-spectrum elevations of cytokine messages at 120D in G93A-SOD1 mice IL12p35 Hensley et al., J. Neurochem. 82: (2002)

L32 GAPDH MIF TNF  IFN  IFN  TGF  1 TGF  2 TGF  nonTg G93A-SOD1 TNF  and TGF  1/2 are also upregulated at 120 D

Glia-activating cytokines are increased in G93A-SOD1 mice in an age-dependent fashion difference at 80 D difference at 120 D % of nonTg % of wt-hSOD % of nonTg TNF  152* 717* TNFRI164* 333*I IL1  217*397* 294* IL1  178*760* 183* IL1RA355*2085* 415* IFN  147* IL6ND155* ND IL IL12-p35235*135* 131 IL18158* MIF116*73* 89 IL2ND 90 IL3ND 99 IL4ND 123

pg / mg protein Analyte NonTg G93A-SOD1% increase TNF  42  7 65  3*55 IFN  1063   91*41 IL6 488   115*52 IL1  0.54   0.10*85 IL1  120   26*37 IL2 456   38*63 IL3 6.2   1.1*44 IL4 1.9   0.1*21 IL5 438   26*36 IL   35*24 IL12p   0.8*28 IL12p   1.6*38 IL   KC 5.8   1.5*53 MIP-1  248   41*30 RANTES 17  334  6*100 GM-CSF 1055   57 5 Cytokines and chemokines are elevated at the protein level in G93A-SOD1 mouse spinal cord

Cytokines induce ROS (I): IL1  Treatment of mixed glial cell culture

Cytokines induce ROS (II): TNF  treatment of Walker EOC-20 microglia TNF  (ng/mL) NO 2 - (  M) at 24 H

Conversely: ROS can induce cytokine transcription in glial cell cultures Gabbita et al., Arch. Biochem. Biophys. 376: 1-13 (2000)

Other sources of ROS in ALS: Arachidonic acid metabolism

nonTg G93A-SOD1 Western: anti-5LOX 80 D (5-fold) 120 D (2-fold) 80 kDa 5-LOX is upregulated in G93A-SOD1 mouse spinal cord

Summary Oxidative stress occurs in the central nervous system (CNS) during aging and disease Very useful and faithful genetic models exist for SOME aspects of human CNS disease There is a close, perhaps non-dissociable relationship between oxidative stress and dysfunctional cytokine networks The G93A-SOD1 mouse is an especially attractive model system for the study of these issues.

Future directions We need more tools! Animal genetic manipulations: To dissect the biochemistry New bioanalytical technologies : To analyze the problem and assess the models Especially we need attention to the protein chemistry and protein-protein interactions

Oklahoma Medical Research Foundation Dr. Robert FloydShenyun Mou Dr. Brian GordonQuentin Pye Dr. Paula GrammasScott Salsman Dr. Ladan HamdeyhariDr. Charles Stewart Dr. Molina MhatreMelinda West Kelly Williamson External Collaborators Dr. Joe Fedynyshyn and Dr. Lindsey Fan, BioRad Laboratories Dr. William Markesbery and Sanders Brown Center on Aging, University of Kentucky, Lexington KY Dr. Flint Beal, Cornell Medical Center Funding support ALS Association National Institute on Aging (R03AG ) Oklahoma Center for Advancement of Science and Technology (HR01-149RS) Oklahoma Center for Neurosciences (OCNS) Acknowledgments

References and Recommended Reading